<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03214497</url>
  </required_header>
  <id_info>
    <org_study_id>Schulthess_Anä_11</org_study_id>
    <nct_id>NCT03214497</nct_id>
  </id_info>
  <brief_title>Protector™ Versus Supreme® Laryngeal Mask Airway</brief_title>
  <official_title>Prospective Randomised Trial of the Protector™ Versus the Supreme® Laryngeal Mask Airway</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Schulthess Klinik</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Schulthess Klinik</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to compare the oropharyngeal leak pressure of the Protector
      Laryngeal mask with the Supreme laryngeal mask. Other secondary parameters will be studied.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The OLP as the primary outcome measurement will be evaluated after insertion of the LMA in
      each group. We hypothesize that there will be a difference of 4 cm H2O between the 2 masks,
      because of the different material and slightly different form of the masks. Secondary
      outcomes will be measured after insertion of the LMA as by protocol. Finally postoperative
      airway morbidity will be evaluated 3 hours after removal of the LMA.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 12, 2017</start_date>
  <completion_date type="Actual">November 28, 2017</completion_date>
  <primary_completion_date type="Actual">November 28, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>OLP</measure>
    <time_frame>5 minutes</time_frame>
    <description>oropharyngeal leak pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>insertion</measure>
    <time_frame>5 minutes</time_frame>
    <description>insertion of LMA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time of insertion</measure>
    <time_frame>5 minutes</time_frame>
    <description>time of Insertion of LMA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brimacombe score</measure>
    <time_frame>5 minutes</time_frame>
    <description>Brimacombe score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>respiratory pressure</measure>
    <time_frame>5 minutes</time_frame>
    <description>maximum respiratory pressure for adequate ventilation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>suctioning catheter</measure>
    <time_frame>5 minutes</time_frame>
    <description>number needed of insertion of suctioning catheter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>suctioning fluids</measure>
    <time_frame>5 minutes</time_frame>
    <description>ml suctioned from suctioning catheter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CO2</measure>
    <time_frame>5 minutes</time_frame>
    <description>endtidal CO2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>blood staining</measure>
    <time_frame>5 minutes</time_frame>
    <description>visible blood staining after removal of the laryngeal mask</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>airway morbidity</measure>
    <time_frame>3 hours</time_frame>
    <description>assess sore throat, neck pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">96</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Protector group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All patients collocated randomly to the Protector Group Primary and secondary outcome Parameters are studied</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supreme group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>All patients collocated randomly to the Supreme Group, Primary and secondary outcome Parameters are studied</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Protector</intervention_name>
    <description>All patients which are assigned to the Protector are studied with this laryngeal mask</description>
    <arm_group_label>Protector group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Supreme</intervention_name>
    <description>All patients which are assigned to the Supreme are studied with this laryngeal mask</description>
    <arm_group_label>Supreme group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18-75

          -  ASA 1-3

          -  Operation on limbs

          -  written informed consent

        Exclusion Criteria:

          -  known difficult airway

          -  anatomical abnormalities on airway, Larynx, oesophagus, stomach

          -  not fastened

          -  high aspiration risk

          -  patients with contraindication of laryngeal mask

          -  BMI &gt;35 kg/m2

          -  patients with disease which impairs accurate Investigation of patient

          -  cardiovascular risk factors

          -  COPD

          -  acute disease where anaesthesia is in doubt

          -  no written consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Berthold Moser, MD, MBA</last_name>
    <role>Principal Investigator</role>
    <affiliation>Schulthess Klinik</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Christian Keller</name>
      <address>
        <city>Zürich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2017</study_first_submitted>
  <study_first_submitted_qc>July 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2017</study_first_posted>
  <last_update_submitted>November 30, 2017</last_update_submitted>
  <last_update_submitted_qc>November 30, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>laryngeal mask</keyword>
  <keyword>Supreme</keyword>
  <keyword>Protector</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

